Your Skin's Natural Antibiotics Can Also Cause Skin Disease — The Double-Edged Sword of Antimicrobial Peptides | Research

The takeaway

Antimicrobial peptides in the skin protect against infections but can also drive inflammatory skin diseases like psoriasis, eczema, rosacea, and acne.

6 skin diseases linked to AMPs
The same antimicrobial peptides that protect against infection also actively contribute to psoriasis, eczema, rosacea, acne, lupus, and systemic sclerosis

What the researchers found

Antimicrobial peptides (AMPs) in the skin are a double-edged sword. On one hand, they protect against infections by killing bacteria, viruses, fungi, and parasites. They also promote wound healing, stimulate cell growth and migration, and strengthen the skin barrier. On the other hand, these same peptides actively contribute to the development and progression of several skin diseases.

The review identifies specific roles in multiple conditions: AMPs drive inflammatory processes in psoriasis, contribute to the altered immune response in atopic dermatitis (eczema), play a role in the redness and inflammation of rosacea, and are involved in acne, lupus, and systemic sclerosis. The key AMPs discussed include defensins, cathelicidins (like LL-37), S100 proteins, ribonucleases, and dermcidin.

Why it matters

This review reframes how we think about the skin's natural defense peptides. For decades, AMPs were seen purely as protective — the body's built-in antibiotics. This paper consolidates evidence that they can also be part of the problem in inflammatory skin diseases. This dual nature has major therapeutic implications: treatments that boost AMPs might help fight infections but could worsen conditions like psoriasis or rosacea, and vice versa.

The numbers in context

5 major AMP families reviewed (defensins, cathelicidins, S100 proteins, ribonucleases, dermcidin) · 6 skin diseases discussed (psoriasis, atopic dermatitis, rosacea, acne, lupus, systemic sclerosis)

How the study worked

This is a narrative review published in Experimental Dermatology that synthesizes published research on the roles of antimicrobial peptides and proteins in skin biology and skin diseases. The authors reviewed literature on five major families of skin-derived AMPs and their involvement in both protective immunity and disease pathogenesis.

Who was studied

Review article — no direct study population

What this study cannot tell us

As a narrative review, this paper summarizes and interprets existing research rather than generating new data. The dual roles of AMPs are described qualitatively; the review does not quantify the balance between protective and pathogenic effects. The relative contribution of AMPs to each skin disease compared to other pathogenic factors is not precisely delineated.

How to read the evidence

This is a comprehensive review published in a respected dermatology journal, synthesizing evidence from many individual studies. Review articles provide strong conceptual frameworks but do not generate new data. The dual role of AMPs is well-supported by the individual studies cited.

When this study was published

Published in 2017, this review remains relevant as the field of AMP biology in skin disease has continued to expand. The fundamental concepts about AMPs' dual nature are well-established.

The bigger picture

The dual nature of antimicrobial peptides reflects a broader theme in immunology: the same immune mechanisms that protect us can also cause disease when dysregulated. As researchers develop AMP-based therapies — whether for wound healing, anti-infection, or anti-aging purposes — this review serves as a critical reminder that enhancing AMPs could have unintended consequences for inflammatory skin conditions. It also suggests that modulating AMPs could be a therapeutic strategy for managing diseases like psoriasis and rosacea.

Questions still open

Could selectively blocking specific AMPs improve inflammatory skin diseases without compromising skin's antimicrobial defense?
Do topical peptide skincare products that include AMP-boosting ingredients risk worsening conditions like rosacea in susceptible individuals?
What determines whether AMPs act protectively versus pathogenically in a given individual — genetics, microbiome, or both?

Common questions

What are antimicrobial peptides in the skin?

Your skin naturally produces small proteins called antimicrobial peptides (AMPs) that act as a first line of defense against germs. Major types include defensins, cathelicidins (like LL-37), and dermcidin. Beyond killing microbes, they also help heal wounds, reduce inflammation, and maintain the skin barrier. They're essentially your skin's built-in immune system.

How can something protective also cause disease?

It's a matter of balance. In normal amounts and at the right time, AMPs protect your skin. But when they're overproduced or produced inappropriately — as happens in psoriasis and rosacea — they trigger excessive inflammation and tissue damage. Think of it like a fire alarm: helpful when there's a real fire, but a serious problem if it keeps going off for no reason.

Read the original research

Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases.

Experimental dermatology, 26(11), 989-998

View on PubMed ↗Publisher’s paper ↗

Citation

Niyonsaba, François; Kiatsurayanon, Chanisa; Chieosilapatham, Panjit; Ogawa, Hideoki. (2017). Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases.. Experimental dermatology, 26(11), 989-998. https://doi.org/10.1111/exd.13314